150 State St., Albany,
NY, USA, 12207
Plasma, which contains a considerable concentration of different proteins, is the most crucial liquid component of the whole blood. Human plasma is a source of many other proteins, but only a few of these proteins are beneficial for producing therapeutic plasma products. It consists mainly of water containing only a small amount of minerals, salts, ions, nutrients, and proteins in the solution. A fraction of a plasma that is a blood component that is collected by the blood fractionation is classified as the various components of the blood plasma. After the fractionation of plasma, a wide range of life-saving products is obtained to prevent, manage, and treat various life-threatening human injuries and diseases, such as coagulation, immunoglobulin, and protease inhibitors, anticoagulants, albumins, and others.
Growing Adoption of Immunoglobulin to Bolster Market Growth
One of the predominant and crucial factors for market growth is the increased use of immunoglobulin to manage, treat and diagnose metabolic diseases worldwide. The high use of immunoglobulin will, therefore, magnify its dominance and improve market prospects. Immunoglobulin is a plasma-derived glycoprotein molecule that acts as an antibody. Constant research and development have been carried out to understand the effectiveness and therapeutic nature of immunoglobulin in treating complex diseases such as Alzheimer's and other autoimmune disorders. These factors are expected to drive the growth of the market cumulatively.
The market for Plasma Fractionation is driven by factors such as an increased amount of hemophilic patients, an increased prevalence of autoimmune diseases, an increasing prevalence of respiratory diseases and a growing generic population. The market is driven mainly by proteins derived from plasma that have several therapeutic applications. Some of the applications of plasma-derived proteins include biomarkers for diagnoses of disease, acute liver failure treatment, maintaining blood volume following traumas in surgery and immunological disorders.
In addition, one of the significant factors contributing to market growth is an increase in the number of hemophilic patients. Hemophilic patients require coagulation factors to be administered daily, which increases the global demand for plasma fractionation products.
In 2019, the global market for plasma fractionation was estimated to be over USD 25 billion. At a CAGR of 6.02 percent from 2019 to 2025, it is expected to grow.
One of the main factors hindering the market's growth is the high cost of plasma-derived protein, Hoverer, due to the costs associated with protein purification. In addition, strict government regulations, limited reimbursement, and the emergence of recombinant proteins as an alternative to proteins derived from plasma are expected to hinder the growth of the market for plasma fractionation to some degree.
In terms of region, the global market for plasma fractionation is divided into five regions: North America, Europe, Latin America, Asia Pacific, the Middle East, and Africa. In 2015, due to rising per capita healthcare spending in the U.S., Increasing demand for improved and advanced health facilities and increased adoption of new and advanced technologies were dominated by North America as a global plasma fractionation market. Due to increasing hemophilia prevalence among countries such as China and India and increasing aging in the Asia Pacific region,the highest CAGR is expected in the Asia Pacific region during the forecast period on the global plasma fractionation market.
By End User
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa and Rest of Middle East & Africa
The report profiles various major market players such as
Competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, company overview, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, technology development, research & development and other market activities). The study also provides company’s positioning and market share of the overall market.
Timeline Considered for Analysis:
- 2019: Base Year
- 2020: Estimated Year
- 2020 to 2025: Forecast Period
Research Scope and Deliverables
Overview & Executive Summary
Market Drivers, Trends, Challenges and Opportunities
Market Size and Forecast Projections
Macroeconomic Indicators of Various Countries Impacting the Growth of the Market
Extensive Coverage of Industry Players including Recent Product Launches and Market Activities
Porter’s Five Force Analysis
Market Segmentation Analysis:
Industry report analyses the global plasma fractionation market by the following segments:
Customization: We also offer customization’s in the industry report as per the company’s specific needs.
Key Questions Answered in the Plasma Fractionation Industry Report
The report offers a comprehensive insight on the Plasma Fractionation Market share, competitor landscape, market trends, growth, revenue, and key driver’s analysis with coverage of key players, top geographies, product types and end user.
Exhaustive secondary research and in-depth primary interviews with industry experts has been conducted to present qualitative and quantitative insights in the report.
We offer customizations as per client’s specific needs.